Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other financing activities (2024)

Immunocore Holdings' Other financing activities history spans 1 years, with the latest figure at $1.1 million for Q2 2024.

  • For Q2 2024, Other financing activities changed N/A year-over-year to $1.1 million; the TTM value through Mar 2025 reached $1.1 million, down 90.88%, while the annual FY2024 figure was $13.4 million, N/A changed from the prior year.
  • Other financing activities for Q2 2024 was $1.1 million at Immunocore Holdings, down from $12.2 million in the prior quarter.
  • Across five years, Other financing activities topped out at $12.2 million in Q1 2024 and bottomed at $1.1 million in Q2 2024.